Login

Financial Snapshot

Revenue
TTM
$819.9M
Gross Margin
TTM
50.38%
Net Income
TTM
-$264.2M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
331.78%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$686.6M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$27.36M

Stock Price

Loading...
Market Cap: $586.65 Million

About Verano Holdings Corp

Verano Holdings Corp. (VRNO) is a U.S. multi-state cannabis operator that cultivates, manufactures, and retails cannabis products across multiple state-licensed markets. Revenue comes from direct-to-consumer retail sales through licensed dispensaries and wholesale distribution of flower, edibles, and concentrates to third-party retailers. Verano competes primarily against other vertically integrated multi-state operators including Green Thumb Industries, Cresco Labs, Curaleaf Holdings, and Trulieve Cannabis Corp. The company operates on a state-by-state basis, as federal law prohibits interstate cannabis transport. George Archos, who signed the FY2025 10-K as Chairman, Chief Executive Officer, and President, leads the company. Total operating expenses for FY2025 were $520,590 thousand, down 23.6% from $681,107 thousand in FY2024. Cost of goods sold for FY2025 was $408,007 thousand, a 6.1% decline from FY2024. The company carries a $195,000,000 senior secured term loan originated March 11, 2026, maturing March 11, 2029.

Revenue model
Transactional retail sales of cannabis products through state-licensed dispensaries, supplemented by wholesale cultivation and distribution revenue to third-party licensees. Cost of goods sold includes flower, edibles, concentrates, packaging, processing fees, rent, and utilities (FY2025 10-K).
Products and services
Cannabis flower, edibles, and concentrates sold under proprietary consumer-packaged goods brands. The company holds approximately 130 active trademarks registered or pending registration as of the FY2025 10-K filing date.
Customers and end markets
Medical cannabis patients and adult-use recreational consumers in U.S. states where cannabis has been authorized at the state level. Operations are confined to state-licensed markets; federal law prohibits interstate cannabis commerce.
Value-chain role
Vertically integrated operator spanning cultivation, manufacturing, and retail dispensary sales within individual state markets.
Geographic exposure
U.S. multi-state footprint operating exclusively within states that have authorized medical or adult-use cannabis programs. Federal law restricts all operations to intrastate commerce.
Competitors
Green Thumb Industries Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., Trulieve Cannabis Corp., Illicit market operators, Psychoactive hemp-based product sellers

Source: SEC 10-K, filed 2026-03-12

Industry: Agricultural Production-Crops Peers: Arvinas Inc Axsome Therapeutics Inc Pacira Biosciences Inc Filana Therapeutics Inc Harmony Biosciences Holdings Inc Johnson & Johnson Revance Therapeutics, Inc. Prestige Consumer Healthcare Inc Ventyx Biosciences, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support